Table 3 Staining results of evaluable cores (%)
From: CD 9 and vimentin distinguish clear cell from chromophobe renal cell carcinoma
CALD | CD9 | CD99 | FABP3 | SERPINA1 | TRPS1 | VIM | ||
|---|---|---|---|---|---|---|---|---|
Clear cell RCC | No stain | 235/235 (100.0) | 215/229 (93.9) | 187/213 (87.8) | 137/232 (59.1) | 105/217 (48.4) | 208/212 (98.1) | 134/220 (60.9) |
Weak | 0/235 (0.0) | 10/229 (4.4) | 21/213 (9.9) | 53/232 (22.8) | 63/217 (29.0) | 2/212 (0.9) | 28/220 (12.7) | |
Strong | 0/235 (0.0) | 4/229 (1.7) | 5/213 (2.3) | 42/232 (18.1) | 49/217 (22.6) | 2/212 (0.9) | 58/220 (26.4) | |
Chomophobe RCC | No stain | 24/24 (100.0) | 0/24 (0.0) | 13/23 (56.5) | 13/24 (54.2) | 1/22 (4.5) | 6/22 (27.3) | 24/24 (100.0) |
Weak | 0/24 (0.0) | 2/24 (8.3) | 7/23 (30.4) | 5/24 (20.8) | 7/22 (31.8) | 11/22 (50.0) | 0/24 (0.0) | |
Strong | 0/24 (0.0) | 22/24 (91.7) | 3/23 (13.0) | 6/24 (25.0) | 14/22 (63.6) | 5/22 (22.7) | 0/24 (0.0) | |
Papillary RCC | No stain | 37/37 (100.0) | 36/36 (100.0) | 20/32 (62.5) | 17/36 (47.2) | 20/34 (58.8) | 31/31 (100.0) | 16/34 (47.1) |
Weak | 0/37 (0.0) | 0/36 (0.0) | 7/32 (21.9) | 9/36 (25.0) | 10/34 (29.4) | 0/31 (0.0) | 10/34 (29.4) | |
Strong | 0/37 (0.0) | 0/36 (0.0) | 5/32 (15.6) | 10/36 (27.8) | 4/34 (11.8) | 0/31 (0.0) | 8/34 (23.5) | |
Unclassified RCC | No stain | 13/13 (100.0) | 10/13 (76.9) | 4/9 (44.4) | 7/13 (53.8) | 6/11 (54.5) | 10/11 (90.9) | 4/12 (33.3) |
Weak | 0/13 (0.0) | 1/13 (7.7) | 3/9 (33.3) | 3/13 (23.1) | 4/11 (36.4) | 1/11 (9.1) | 2/12 (16.7) | |
Strong | 0/13 (0.0) | 2/13 (15.4) | 2/9 (22.2) | 3/13 (23.1) | 1/11 (9.1) | 0/11 (0.0) | 6/12 (50.0) | |
Urothelial carcinoma | No stain | 45/45 (100.0) | 46/46 (100.0) | 38/43 (88.4) | 29/46 (63.0) | 23/47 (48.9) | 38/44 (86.4) | 40/43 (93.0) |
Weak | 0/45 (0.0) | 0/46 (0.0) | 4/43 (9.3) | 12/46 (26.1) | 19/47 (40.4) | 5/44 (11.4) | 1/43 (2.3) | |
Strong | 0/45 (0.0) | 0/46 (0.0) | 1/43 (2.3) | 5/46 (10.9) | 5/47 (10.6) | 1/44 (2.3) | 2/43 (4.7) | |
Oncocytoma | No stain | 16/16 (100.0) | 7/16 (43.8) | 1/13 (7.7) | 3/16 (18.75) | 13/16 (81.3) | 9/15 (60.0) | 16/16 (100.0) |
Weak | 0/16 (0.0) | 6/16 (37.5) | 2/13 (15.4) | 6/16 (37.5) | 2/16 (12.5) | 4/15 (26.7) | 0/16 (0.0) | |
Strong | 0/16 (0.0) | 3/16 (18.8) | 10/13 (76.9) | 7/16 (43.8) | 1/16 (6.3) | 2/15 (13.3) | 0/16 (0.0) | |
Angiomyolipoma | No stain | 1/11 (9.1) | 10/10 (100.0) | 5/10 (50.0) | 7/10 (70.0) | 3/11 (27.3) | 7/12 (58.3) | 6/8 (75.0) |
Weak | 0/11 (0.0) | 0/10 (0.0) | 5/10 (50.0) | 3/10 (30.0) | 5/11 (45.5) | 5/12 (41.7) | 1/8 (12.5) | |
Strong | 10/11 (90.9) | 0/10 (0.0) | 0/10 (0.0) | 0/10 (0.0) | 3/11 (27.3) | 0/12 (0.0) | 1/8 (12.5) |